Patented drug tariffs: India more or less shielded, says GTRI

Patented drug tariffs: India more or less shielded, says GTRI

U.S. President Trump signed an executive order, announcing the imposition of a 100% ad valorem duty on the import of certain patented pharmaceuticals and associated pharmaceutical ingredients

Original Source

Read the full article at Thehindu →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.